Latest Board Renewal News

Lindian Resources has secured a US$50 million non-binding funding term sheet with Gerald Group, progressing its Kangankunde Rare Earths Project, while also signing a 10-year lease for its Woula bauxite project in Guinea and navigating significant board changes.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.